Skip to search formSkip to main contentSkip to account menu

AEZS 124

Known as: AEZS-124, AEZS124 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Effective treatment of triple-negative breast cancer with targeted cytotoxic somatostatin analogue AN-162 (AEZS-124).
619 Background: Triple negative breast cancers (TNBC) represent a distinct subtype of breast cancer being negative to ER, PR and… 
2013
2013
324 TARGETED CYTOTOXIC ANALOG OF SOMATOSTATIN AN-162 [AEZS-124] INHIBITS PROLIFERATION OF PC-3 AND DU-145 HUMAN ANDROGEN-INDEPENDENT PROSTATE CANCERS IN VITRO AND IN VIVO
2009
2009
Effektive zielgerichtete Therapie mit dem neuen zytotoxischen Somatostatinanalog AN-162 [AEZS-124] in humanen Mammakarzinom Modellen
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)